Morningside Venture Investments Ltd - Dec 31, 2022 Form 5 Insider Report for Amylyx Pharmaceuticals, Inc. (AMLX)

Role
10%+ Owner
Signature
/s/ Frances Anne Elizabeth Richard, Director
Stock symbol
AMLX
Transactions as of
Dec 31, 2022
Transactions value $
$0
Form type
5
Date filed
1/11/2023, 03:07 PM
Previous filing
Jan 5, 2023
Next filing
Jan 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMLX Common Stock Gift $0 -170K -1.88% $0.00 8.89M Sep 12, 2022 Direct
transaction AMLX Common Stock Gift $0 -340K -3.83% $0.00 8.55M Sep 12, 2022 Direct
transaction AMLX Common Stock Gift $0 -33.3K -0.39% $0.00 8.51M Sep 20, 2022 Direct
transaction AMLX Common Stock Gift $0 -833K -9.79% $0.00 7.68M Sep 23, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.